Human T-cell leukemia viruses: Epidemiology, biology, and pathogenesis

Blood Reviews

Volumn 11, Issue 2, 1997, Pages 91-104

  Ferreira Jr , O C ^b   Planelles, V ^b   Rosenblatt, J D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; DANAZOL; DOXORUBICIN; ETOPOSIDE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOXANTRONE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VINDESINE; ZIDOVUDINE;

HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS PATHOGENESIS;

EID: 12644304238     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(97)90015-1     Document Type: Article

References (175)

1. Poiesz BJ, Ruscetti FW, Gazdar AF et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419.
2. Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemic antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-6480.
3. Clark JW, Robert-Guroff M, Ikehara O, Henzan E, Blattner WA. Human T-cell leukemia-lymphoma virus type I and adult T-cell leukemia-lymphoma in Okinawa. Cancer Research 1985; 45: 2849-2852.
4. Blattner WA, Kalyanaraman VS, Robert-Guroff M et al. The human type C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 1982; 30: 257-264.
5. Wiktor SZ, Piot P, Mann JM et al. Human T-cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. J Infect Dis 1990; 161: 1073-1077.
6. Delaporte E, Dupont A, Peeters M et al. Epidemiology of HTLV-I in Gabon (Western Equatorial Africa). Int J Cancer 1988; 42: 687-689.
7. Blayney DW, Blattner WA, Robert-Guroff M et al. The human T-cell leukemia-lymphoma virus in the Southeastern United States. JAMA 1983; 250: 1048-1052.
8. Yanagihara R, Jenkins CL, Alexander SS, Mora CA, Garruto RM. Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis. J Infect Dis 1990; 162: 649-654.
9. Nogueira CM, Cavalcanti M, Schechter M, Ferreira OC Jr. Human T lymphotropic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brazil. Vox Sang 1996; 70: 47-48.
10. Meytes D, Schochat B, Lee H et al. A serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet 1990; 336: 1533-1535.
11. Singhai BS, Lalkaka JA, Sonoda S et al. Human T-lymphotropic virus type I infections in Western India. AIDS 1993; 7: 138-139.
12. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY. High rate of HTLV-II infection in seropositive IV drug abusers from New Orleans. Science 1989; 244: 471-475.
13. Krook A, Blomberg J. HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994; 26: 129-132.
14. Gabbai AA, Bordin JO, Vieira Filho JPB et al. Selectivity of human T-lymphotropic virus type-I (HTLV-I) and HTLV-II infection among different populations in Brazil. Am J Trop Med Hyg 1993; 49: 664-671.
15. Fukushima Y, Takahashi H, Hall W et al. Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res Human Retroviruses 1995; 11: 637-644.
16. Levine PH, Jacobson S, Elliott R et al. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993; 9: 123-127.
17. Feigenbaum F, Fang C, Sandier SG. Human T-lymphotropic virus type II in Panamanian Guaymi Indians. Transfusion 1994; 34: 158-161.
18. Biglione M, Gessain A, Quiruelas S, Fay O, Taborda MA, Fernandez E. Endemic HTLV-II infection among Tobas and Matacos Amerindians from North Argentina. J Acquir Immun Defic Syndr 1993; 6: 631-633.
19. Lal RB, Povoa M, Lal AA. Seroprevalence of HTLV-II in Paragaminos, State of Para, Brazil. J Acquir Immun Defic Syndr 1992; 6: 634-636.
20. Fujiyama C, Fujiyoshi T, Miura T et al. A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia. J Infect Dis 1993; 168: 1075-1077.
21. Cartier L, Araya F, Castillo JL et al. Southernmost carriers of HTLV-I/II in the world. Jpn J Cancer Res 1993; 84: 1-3.
22. Goubou P, Desmyter J, Ghesquiere J, Kasereka B. HTLV-II among pygmies. Nature 1992; 359: 201.
23. Wiktor SZ, Pate EJ, Murphy EL et al. Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes. J Acquir Immune Defic Syndr 1993; 6: 1162-1167.
24. Takahashi K, Takezaki T, Oki T et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. Int J Cancer 1991; 49: 673-677.
25. Nyambi P, Ville Y, Louwagie J et al. Mother-to-child transmission of human T-cell lymphotropic virus types I and Il (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 187-192.
26. Kusuhara K, Sonoda S, Takahashi K, Tokugawa K, Fukushige J, Ueda K. Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa. Japan. Int J Cancer 1997; 40: 755-757.
27. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H. Okochi K. Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis 1986; 154: 851-857.
28. Murphy EL, Figueroa JP, Gibbs WN et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I), Ann Intern Med 1989; 111: 555-560.
29. Kaplan J, Khabbaz R, Murphy E et al. Male-to-female transmission of human T-cell lymphotropic virus types 1 and II: association with viral load. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 193-201.
30. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46: 245-253.
31. Kamihira S, Nakasima S, Oyakawa Y et al. Transmission of human T-cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang 1987; 52: 43-44.
32. Manns A, Wilks RJ, Murphy EL et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51: 886-891.
33. Gout O, Baulac M, Gessain A et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383-387.
34. Shimotohno K., Takahashi Y, Shimizu N et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci 1985; 82: 3101-3105.
35. Constantine N. Serologic tests for the retroviruses: approaching a decade of evolution. AIDS 1993; 7: 1-13.
36. Update: serologic testing for human T-lymphotropic virus type I - United States, 1989 and 1990. MMWR 1992; 41: 259-262.
37. Rosenblatt JD, Zack JA, Chen ISY, Lee H. Recent advances in detection of human T-cell leukemia viruses type I and II infection. Nat Immun Cell Growth Regul 1990; 9: 143-149.
38. Viscidi R, Hill P, Li S et al. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. J Acquir Immune Defic Syndr 1991; 4: 1190-1198.
39. Malik KTA, Even J, Karpas A. Molecular cloning and complete nucleotide sequence of an adult T-cell leukemia virus/human T-cell leukemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup. J Gen Virol 1988; 69: 1695-1710.
40. Gessain A, Yanagihara R, Franchina G et al. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc Natl Acad Sci 1991; 88: 7694-7698.
41. Gessain A, Gallo R, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992; 66: 2288-2295.
42. Miura T, Fukunaga T, Igarashi T et al. Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc Natl Acad Sci USA 1994; 91: 1124-1127.
43. Komurian F, Pelloquin F, de The G. In vivo genomic variability of human T-cell leukemia virus type 1 depends more upon geography than upon pathologies. J Virol 1991: 65: 3770-3778.
44. Liu H-F, Vandamme A-M, van Brussel M, Desmyter J, Goubou P. New retroviruses in human and simian T-lymphotropic viruses. Lancet 1994; 344: 265-266.
45. Lee H, Idler KB, Swanson P et al. Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from US blood donors and US and Italian IV drug users. Virology 1993; 196: 57-69.
46. Takahashi H, Zhu S, Ijichi S et al. Nucleotide sequence analysis of human T cell leukemia virus, Type II (HTLV-II) isolates. AIDS Res Hum Retroviruses 1993; 9: 721-732.
47. Pardi D, Kaplan J, Coligan J et al. Identification and characterization of an extended tax protein in human T-cell lymphotropic virus type II subtype b isolates. J Virol 1993; 67: 7663-7667.
48. Eiraku N, Novoa P, Ferreira M. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type II. J Virol 1996; 70: 1481-1492.
49. Switzer WM, Pieniazek D, Swanson P et al. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995; 69: 621-632.
50. Hall WW, Kubo T, Ijichi S, Takahashi H, Zhu SW. Human T-cell leukemia/lymphoma virus, type II (HTLV-II): emergence of an important newly recognized pathogen. Sem Virol 1994; 5: 165-178.
51. Seiki M, Hattori S, Yoshida M. Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci USA 1982; 79: 6899-6902.
52. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci 1983; 80: 3618-3622.
53. Mador N, Panet A, Honigman A. Translation of gag, pro and pol gene product of human T-cell leukemia virus type II. J Virol 1989; 63: 2400-2404.
54. Slamon DJ, Shirnotohno K, Cline MJ et al. Identification of the putative transforming protein of the human t-cell leukemia viruses HTLV-I and HTLV-II. Science 1984; 226: 61-65.
55. Lee TH, Coligan JE, Sodroski JG et al. Antigens encoded by the 3́-terminal region of human T-cell leukemia virus: evidence for a functional gene. Science 1984; 226: 57-61.
56. X-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1985; 82: 8359-8363.
57. x-b of human T-cell leukemia virus type II. FEBS 1986; 209: 289-294.
58. Orita S, Saiga A, Takagi S et al. A novel alternatively spliced viral mRNA transcribed in cells infected with human T-cell leukemia virus type I is mainly responsible for expressing p21x protein. FEBS Lett 1991; 295: 127.
59. Furukawa K, Furukawa K, Shiku H. Alternatively spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome. FEBS Lett 1991; 295: 141.
60. Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol 1992; 66: 1737-1745.
61. Zhao LJ, Giam CZ. Interaction of the human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc Natl Acad Sci USA 1991; 88: 11445-11449.
62. Rosenblatt JD, Miles S, Gasson JC, Prager D. Transactivation of cellular genes by human retroviruses. In: Chen ISY, Koprowski H, Svinivasan A, Vogt PK, eds. Transacting Functions of Human Retroviruses, Clinical Topics in Microbiology and Immunology. New York: Springer Verlag, 1995.
63. Jeang KT, Widen SG, Semmes IV OJ, Wilson SH. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science 1990; 247: 1082-1084.
64. Prager D, Rosenblatt JD, Ejima E. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leukemia Lymphoma 1994; 14: 395-400.
65. Rosenblatt JD, Cann AJ, Slamon DJ et al. HTLV-II transactivation is regulated by two overlapping nonstructural genes. Science 1988; 240: 916-919.
66. Black AC, Ruland CT, Yip MT et al. Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol 1991; 65: 6645-6653.
67. Bakker A, Li X, Ruland CT, Stephens DW, Black AC, Rosenblatt JD. Human T-cell leukemia virus type II Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation. J Virol 1996; 70: 5511-5518.
68. Black AC, Chen ISY, Arrigo SJ et al. Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5′ long terminal repeat. Virology 1991; 181: 433-444.
69. Watanabe CT, Rosenblatt JD, Bakker A et al. Negative regulation of gene expression from the HTLV-II LTR by Rex: functional and structural dissociation from positive post-transcriptional regulation. AIDS Res Hum Retroviruses 1996; 12(6): 535-546.
70. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481-492.
71. Deeper JM, Leonard WJ, Kronke M, Waldmann TA, Greene WC. Augmented T-cell growth receptor expression in HTLV-I-infected human leukemic T-cells. J Immunol 1984; 133: 1691-1695.
72. Tajima K, Kuroishi T. Estimation or rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 1985; 15: 423-430.
73. Murphy EL, Hanchard B, Figueroa JP et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43: 250-253.
74. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haem 1991; 79: 428-437.
75. Davey FR, Hutchison RE. Pathology and immunology of adult T-cell leukemia/lymphoma. Curr Opin Oncol 1991; 3: 13-20.
76. Kaplan JE, Osame M, Kubota H et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immun Defic Syndr 1990; 3: 1096-1101.
77. Vernant J, Maurs L, Gessain A et al. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol 1987; 21: 123-130.
78. Osame M, Matsumoto J, Usuku K et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia like cells. Ann Neurol 1987; 21: 117-122.
79. Kira J, Fujihara K, Itoyama Y et al. Leukoencepholopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 1991; 106: 41-49.
80. Akizuki S, Setoguchi M, Nakazato O et al. Case studies: an autopsy case of human T-lymphotropic virus type I-associated myelopathy. Hum Pathol 1988; 19: 988-990.
81. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990; 96: 103-123.
82. Morgan O, Mora C, Rodgers-Johnson P et al. HTLV-I and polymyositis in Jamaica. Lancet 1989; 2: 1184-1186.
83. Nishioka K, Nakajima T, Hasunuma T et al. Rheumatic manifestation of human leukemia virus infection. Rheum Dis Clin N Am 1993; 19: 489-503.
84. Mochizuki M, Watanabe T, Yamaguchi K et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992; 83: 236-239.
85. LeGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336: 1345-1347.
86. Patey O, Gessain A, Breuil J et al. Seven years of recurrent severe strongyloidiasis in an HTLV-I-infected man who developed adult T-cell leukemia. AIDS 1992; 6: 575-579.
87. Mochizuki M, Tajima K, Watanabe T, Yamaguchi K. Human T lymphotropic virus type I uveitis. Br J Ophthalmol 1994; 78: 149-154.
88. Sagawa K, Mochizuki M, Masuoka K et al. Immunopathological mechanism of human T-cell lymphotropic virus type I (HTLV-I) uveitis. J Clin Invest 1995; 95: 852-858.
89. Yamamoto K, Aono H, Nakajima T, Hasunuma T, Nishioka K. Oligoclinal proliferation of human T-cell leukemia virus type I infected lymphocytes in lesions of virus-induced arthropathy. Biochem Biophys Res Commun 1995; 208: 1040-1045.
90. Iwakura Y, Tosu M, Yoshida E et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991; 253: 1026-1028.
91. Hall WW, Liu CR, Schneewind O et al. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 1991; 253: 317-320.
92. Zucker-Franklin D, Hooper W, Evatt B. Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood 1991; 80: 1537-1545.
93. Ghosh S, Abrams J, Terunuma H et al. Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood 1994; 84: 2663-2671.
94. Pancake BA, Wassef EH, Zucker-Franklin D. Demonstration of antibodies to human T-cell lymphotropic virus-I tax in patients with the cutaneous T-cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus. Blood 1996; 88: 3004-3009.
95. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571-573.
96. Rosenblatt JD, Golde DW, Wachsman W et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986; 313: 372-377.
97. Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S. Incidence of hairy cell leukemia, mycosis fungoides and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 1991; 163: 435-440.
98. Loughran T, Coyle T, Sherman M et al. Detection of human T-cell leukemia/lymphoma virus, Type II, in a patient with large granular lymphocytic leukemia. Blood 1992; 80: 1116-1119,
99. Ijichi S, Ramundo MB, Takahashi H, Hall WW. In vivo cellular tropism of human T-cell leukemia virus type II. J Exp Med 1992; 176: 293-296.
100. Harrington W, Sheremata W, Hjelle B et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993; 33: 411-414.
101. Hjelle B, Appenzeller O, Mills R et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339: 645-646.
102. Rosenblatt JD, Tomkins P, Rosenthal M et al. Progressive spastic myelopathy in a patient co-infected with HIV-I and HTLV-II: autoantibodies to the human homologue of rig in blood and cerebrospinal fluid. AIDS 1992; 6: 1151-1158.
103. Jacobson S, Lehky T, Nishimura M et al. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993; 33: 392-396.
104. Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecificintegration of the HTLV provirus genome into adult T-cell leukemia cells. Nature 1984; 309: 640-642.
105. Kimata JT, Palker TJ, Ratner L. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J Virol 1993; 67: 3134-3141.
106. Gessain A, Saal F, Giron M-L et al. Cell surface phenotype and human T lymphotropic virus type I antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis. J Gen Virol 1990; 71: 333-341.
107. Fukudome K, Furuse M, Fukuhara N et al. Strong induction of ICAM-1 in human T-cells transformed by human T-cell-leukemia virus type I and depression of LFA-1 in adult T-cell-leukemia-derived cell lines. Int J Cancer 1992; 52: 418-427.
108. Crenon I, Béraud C, Simard P, Montagne J, Veschambre P, Jalinot P. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2Rα κB enhancer include the product of the c-rel proto-oncogene. Oncogene 1993; 8: 867-875.
109. Suzuki T, Hirai H, Murakami T, Yoshida M. Tax protein of HTLV-I destabilizes the complexes of NF-κB and IκB and induces nuclear translocation of NF-κB for transcriptional activation. Oncogene 1995; 10: 1199-1207.
110. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993; 73: 5-8.
111. Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL. Identification and purification of human STAT proteins activated in response to interleukin-2. Immunity 1995; 2: 321-329.
112. Xu X, Kang S-H, Heidenreich O, Okerholm M, O'Shea JJ, Nerenberg MI. Constitutive activation of different jak tyrosine kinases in human T-cell leukemia virus type I (HTLV-I) Tax protein or virus-transformed cells. J Clin Invest 1995; 96: 1548-1555.
113. Migone T-S, Lin J-X, Cereseto A et al. Constitutive activated Jak-STAT pathway in T-cells transformed with HTLV-I. Science 1995; 269: 79-81.
114. c chains and affects their expression on the cell surface. J Virol 1996; 70: 3599-3605.
115. Franchini G, Wong-Staal, Gallo RC. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc Natl Acad Sci 1984; 81: 6207-6211.
116. + in adult T-cell leukemia. N Engl J Med 1979; 300: 921.
117. Whang-Peng J, Bunn PA, Knutsen T et al. Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemialymphoma in the United States. J Natl Cancer Inst 1985; 74: 357-369.
118. Sugito S, Yamato K., Sameshima Y, Yokota J, Yano S, Miyoshi I. Adult T-cell leukemia: structures and expression of the p53 gene. Int J Cancer 1991; 49: 880-885.
119. Bertini R, Luini W, Sozzani S et al. Identification of MIP-lα/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4. AIDS Res Hum Retroviruses 1995; 11: 155-160.
120. Furukawa Y, Fujisawa J, Osame M et al. Frequent clonal proliferation of human T-cell leukemia virus type I (HTLV-I)-infected T-cells in HTLV-I-associated myelopathy (HAM-TSP). Blood 1992; 80; 1012-1016.
121. Gessain A, Louie A, Gout O, Gallo RC, Franchini G. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. J Virol 1991; 65: 1628-1633.
122. Furukawa Y, Osame M, Kubota R, Tara M, Yoshida M. Human T-cell leukemia virus type-1 (HTLV-I) tax is expressed at the same level in infected cells of HTLV-I-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995; 85: 1865-1870.
123. Hollsberg P, Haffler DA. What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis? Ann Neurol 1995; 37: 143-145.
124. + cytotoxic lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245-248.
125. Elovaara I, Koenig S, Brewah AY et al. High human T-cell lymphotropic virus type I (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-II-associated neurologic disease. J Exp Med 1993; 177: 1567-1573.
126. Lehky TJ, Fox CH, Koenig S et al. Detection of human T lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 37: 167-175.
127. Moore GRW, Traugott U, Scheinberg LC, Rame CS. Tropical spastic paraparesis: a model of virus-induced cytotoxic T-cell mediated demyelination? Ann Neurol 1989; 26: 523-530.
128. Mori H, Ban N, Kinishita K. Familial occurrence of HTLV-I-associated myelopathy. Ann Neurol 1988; 23: 98.
129. Usuku K, Nishizawa M, Matsuki K et al. Association of a particular amino acid sequence of the HLA-DR β1 chain with HTLV-I-associated myelopathy. Eur J Immunol 1990; 20: 1603-1606.
130. Tendler CL, Greenberg SJ, Burton JD et al. Cytokine induction in HTLV-I-associated myelopathy and adult T-cell leukemia: alternate molecular mechanism underlying retroviral pathogenesis. J Cell Biochem 1991; 46: 302-311.
131. Hara H, Morita M, Iawaka T et al. Detection of human T lymphotropic virus type I (HTLV-I) proviral DNA and analysis of T-cell receptor Vβ CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 1994; 180: 831-839.
132. Wattel E, Vartanian J-P, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carrier without malignancy. J Virol 1995; 69: 2863-2868.
133. Harrington W, Sheremata W, Snodgrass S et al. Tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses 1991; 7: 1031-1034.
134. Donaldson VH. Danazol. Am J Med 1989; 87: 49-55.
135. Lymphoma Study Group. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk Res 1991; 15: 81-90.
136. Taguchi H, Kinoshita K. Takatsuki K et al. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine. ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Synd Hum Retrovirol 1996; 12: 182-186.
137. Tsukasaki K, Ikeda S, Murata K et al. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk Res 1993; 17: 157-166.
138. Kuwazuru Y, Hanada S, Furukawa T et al. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990; 76: 2065-2071.
139. Gill P, Harrington W, Kaplan M et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995; 332: 1744-1748.
140. Hermine A, Bouscary D, Gessain A et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995; 332: 1749-1751.
141. Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H. Interleukin-2 receptor (Tac antigen) expressed on adult T-cell leukemia cells. J Clin Invest. 1988; 76: 1805-1810.
142. Waldmann TA, White JD, Goldman CK et al. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 1993; 82: 1701-1712.
143. Waldmann TA, White JD, Carrasquillo JC et al. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood 1995; 86: 4063-4075.
144. 486 IL-2) in patients with chronic lymphocytic leukemia. Lancet 1991; 337: 1124-1125.
145. Saigo K, Shiozawa S, Shiozawa K et al. Alpha-inteferon treatment for adult T-cell leukemia: low levels of circulating alpha-interferon and its clinical effectiveness. Blut 1988; 56: 83-86.
146. Matsushima M, Yoneyama A, Nakamura T et al. A first case of complete remission of beta-interferon sensitive adult T-cell leukemia. Eur J Haematol 1987; 39: 282-287.
147. Tamura K, Makino S, Araki Y, Imamura T, Seita M. Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer 1987; 59: 1059-1062.
148. Koyama Y, Tanaka Y, Oda S, Yamashita U, Eto S. Antiviral and antiproliferative activities of recombinant human interferon alpha 2, beta and gamma on HTLV-I and ATL cells in vitro. Sangyo Ika Daigaku Zasshi 1990; 12: 149-161.
149. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995; 86: 3619-3639.
150. Alexandropoulos K, Cheng G, Baltimore D. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci USA 1995; 92: 3110.
151. Franchini G, Mulloy JC, Koralnik IJ The human t-cell leukemia/lymphotropic virus type Ip 12′ protein cooperates with the E5 oncoprotein and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J Virol 1993; 67: 7701.
152. Schlegel R, Wade-Glass M, Rabson MS, Chung Yang Y. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science 1986; 233: 464.
153. Nelson N. Structure, molecular genetics, and evolution of vacuolar H+ ATPases. J Bioenerg Biomembr 1989; 21: 553.
154. tax, or envelope expression. J Virol 1994; 68: 3448.
155. Green PL, Ross TM, Chen IS, Pettiford S. Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J Virol 1995; 69: 387.
156. Jeang KT, Boros I, Brady M, Radonovich M, Khoury G. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40 responsive 21-base-pair sequence. J Virol 1988; 62: 4499.
157. Suzuki T, Fujsawa J, Toita M, Yoshida M. The trans-activator Tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-I. Proc Natl Acad Sci USA 1993; 90: 610.
158. Bosselut R, Duvall JF, Gegonne A et al. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T-cell leukemia virus HTLV-I. EMBO J 1990; 9: 3137.
159. Gitlin SD, Bosselut R, Gegonne A, Ghysdael J, Brady JN. Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I. J Virol 1991; 65: 5513.
160. Bosselut R, Lim F, Rommond P-C, Frampton J, Brady J, Ghysdael J. Myb protein binds to multiple sites in the human T-cell lymphotropic virus type I long terminal repeat and transactivates LTR-mediated expression. Virology 1992; 186: 764.
161. Lindholm PF, Marriott SJ, Gitlin SD, Bohan CA, Brady JN: Induction of nuclear NF-κB DNA binding activity after exposure of lymphoid cells to soluble Tax1 protein. New Biol 1990; 2: 1034.
162. Marriott SJ, Lindholm PF, Reid RL, Brady JN. Soluble HTLV-I Taxi protein stimulates proliferation of human peripheral blood lymphocytes. New Biol 1991; 3: 678.
163. Marriott SJ, Trinh D, Brady JN. Activation of interleukin 2 receptor alpha expression by extracellular HTLV-I tax 1 protein: a potential role in HTLV-I pathogenesis. Oncogene 1992; 7: 1749.
164. Hanly SM, Rimsky LT, Malim MH et al. Comparative analysis of the HTLV-I rex and HIV-I rev trans-regulatory proteins and their RNA response elements. Genes Dev 1989; 3: 1534.
165. Rimsky L, Hauber J, Dukovich M et al. Functional replacement of the HIV-I rev protein by the HTLV-I rev protein. Nature 1988; 335: 738.
166. Itoh M, Inoue J I, Toyoshima H, Akizawa T, Higashi M, Yoshida M. HTLV-I rex and HIV-I rev act through similar mechanisms to relieve suppression of unspliced RNA expression. Oncogene 1989; 4: 1275.
167. Nosaka T, Siomi H, Adachi Y et al. Nucleolar targeting signal of human T-cell leukemia virus type I Rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA. Proc Natl Acad Sci USA 1989; 86: 9798.
168. Siomi H, Shida H, Nam SH, Nosaka T, Maki M, Hatanaka M. Sequence requirements for nucleolar localization of human T-cell leukemia virus type I pX protein which regulates viral RNA processing. Cell 1988; 55: 197.
169. Unge D, Solomin L, Mellini M, Derse D, Felber BK, Pavlakis GN. The rex regulatory protein of HTLV-I binds specifically to its target within the viral RNA. Proc Natl Acad Sci USA 1991; 88: 7145.
170. Bogerd HP, Tiley LS, Cullen BR. Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element. J Virol 1992; 66: 7572.
171. Grassman R, Berchtold S, Aepinus C, Ballaun C, Boehnlein E, Fleckenstein F. In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts. J Virol 1991; 65: 3721.
172. Yip MT, Dynan WS, Green PL et al. Human T-cell leukemia virus (HTLV) type II rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type I rev-responsive elements. J Virol 1991; 65: 2261.
173. Seiki M, Inoue JL, Hidaka M, Yoshida M. Two cis-acting elements responsible for post-transcriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988; 85: 7124.
174. Ballaun C, King Farrington G, Dubrovnik M, Rusche J, Hauber J, Bohnlein E. Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of rex protein correlates with in vivo activity. J Virol 1991; 65: 4408.
175. Koyanagi Y, Itoyama Y, Nakamura N et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993; 196: 25-33.